These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24439861)

  • 1. High dose statins should be used in all patients undergoing percutaneous coronary intervention.
    Sardella G; Lucisano L
    Int J Cardiol; 2014; 172(1):e139. PubMed ID: 24439861
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.
    Cay S; Cagirci G; Sen N; Balbay Y; Durmaz T; Aydogdu S
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):41-7. PubMed ID: 20217203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
    Nusca A; Melfi R; Patti G; Sciascio GD
    Future Cardiol; 2010 Sep; 6(5):579-89. PubMed ID: 20932108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention.
    Takano H; Ohba T; Yamamoto E; Miyachi H; Inui K; Kawanaka H; Kamiya M; Kikuchi A; Takahashi Y; Tanabe J; Inami S; Takagi G; Asai K; Yasutake M; Ibuki C; Tanaka K; Kusama Y; Seino Y; Munakata K; Mizuno K;
    Am J Cardiol; 2013 Jun; 111(12):1688-93. PubMed ID: 23507709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose statins should be used in all patients undergoing percutaneous coronary intervention.
    Cay S; Durmaz T; Canpolat U; Aydogdu S
    Int J Cardiol; 2013 Oct; 168(5):5103-4. PubMed ID: 23962786
    [No Abstract]   [Full Text] [Related]  

  • 9. Sunrise of statins after AURORA and 4D?
    Wanner C; Krane V
    J Am Soc Nephrol; 2011 Jul; 22(7):1184-6. PubMed ID: 21680649
    [No Abstract]   [Full Text] [Related]  

  • 10. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
    Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E
    JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of complications after percutaneous coronary interventions with statins].
    Mega S; Nusca A; Patti G
    Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin loading before percutaneous coronary intervention to reduce periprocedural myocardial infarction.
    Norris DM; Anderson JR
    Cardiol Rev; 2012; 20(6):319-24. PubMed ID: 22874885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.
    Di Sciascio G; Patti G; Pasceri V; Gaspardone A; Colonna G; Montinaro A
    J Am Coll Cardiol; 2009 Aug; 54(6):558-65. PubMed ID: 19643320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D; Bybee KA
    Heart Vessels; 2006 May; 21(3):146-51. PubMed ID: 16715188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].
    Lin ZP; Shu PC; Liao ZJ; Wang XQ; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1789-91. PubMed ID: 22027793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting and evaluating the details of the JUPITER study.
    Neft M
    Am Fam Physician; 2010 Sep; 82(6):571-7; author reply 571-7. PubMed ID: 20842982
    [No Abstract]   [Full Text] [Related]  

  • 18. HDL cholesterol and residual risk of first cardiovascular events.
    Saely CH; Vonbank A; Drexel H
    Lancet; 2010 Nov; 376(9754):1738; author reply 1738-9. PubMed ID: 21093648
    [No Abstract]   [Full Text] [Related]  

  • 19. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovičová L; Tomašov P; Tesař D
    Am J Cardiol; 2011 May; 107(9):1295-9. PubMed ID: 21349484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.